Zonulin as marker of pregnancy induced hypertension: a case control study
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Zonulin has been implicated in many metabolic disorders including hypertension and obesity. However, there is insufficient information about the involvement of zonulin in pregnancy induced hypertension (PIH) which comprises preeclampsia (PE) and gestational hypertension (GH). This study was therefore aimed at finding the level of this biochemical marker of regulation of tight junctions among women with PIH. Methods: A total of 88 women with PIH and 60 age and body mass index (BMI) matched healthy pregnant women controls were enrolled. Blood pressure at 11–13 weeks and after 20 weeks of gestation, body mass index (BMI) in addition to serum Zonulin levels and lipid profile were compared between the groups. Student’s t-test was used for comparisons of the mean between the two groups. Correlation analyses were performed using Pearson’s correlation and binary logistic regression was used to evaluate the factors associated with PIH. Results: Zonulin level was significantly higher in the participants with PIH as compared to the normal pregnant controls 56.81 ± 7.72 ng/ml vs 40.4 ± 8.60 ng/ml p < 0.0001 and had strong positive correlation with PIH (OR = 1.805; CI1.139–1.275; p < 0.0001). However, the association between first trimester lipids and PIH was weak. Conclusion: The results showed a strong positive correlation between zonulin and PIH, thus changes in intestinal permeability occur in early stages of pregnancy and may be involved in the pathogenesis of PIH.
Abstract
Background: Zonulin has been implicated in many metabolic disorders including hypertension and obesity. However, there is insufficient information about the involvement of zonulin in pregnancy induced hypertension (PIH) which comprises preeclampsia (PE) and gestational hypertension (GH). This study was therefore aimed at finding the level of this biochemical marker of regulation of tight junctions among women with PIH. Methods: A total of 88 women with PIH and 60 age and body mass index (BMI) matched healthy pregnant women controls were enrolled. Blood pressure at 11–13 weeks and after 20 weeks of gestation, body mass index (BMI) in addition to serum Zonulin levels and lipid profile were compared between the groups. Student’s t-test was used for comparisons of the mean between the two groups. Correlation analyses were performed using Pearson’s correlation and binary logistic regression was used to evaluate the factors associated with PIH. Results: Zonulin level was significantly higher in the participants with PIH as compared to the normal pregnant controls 56.81 ± 7.72 ng/ml vs 40.4 ± 8.60 ng/ml p < 0.0001 and had strong positive correlation with PIH (OR = 1.805; CI1.139–1.275; p < 0.0001). However, the association between first trimester lipids and PIH was weak. Conclusion: The results showed a strong positive correlation between zonulin and PIH, thus changes in intestinal permeability occur in early stages of pregnancy and may be involved in the pathogenesis of PIH.
참고문헌 (27)
- Fasano A, "Zonulin and its regulation of intestinal barrier function : the biological door to inflammation, autoimmunity, and cancer", Physiol Rev, 91, pp.151~175 (2011)
- Li C, "Zonulin regulates intestinal permeability and facilitates enteric bacteria permeation in coronary artery disease", Sci Rep, 6, pp.29142~ (2016)
- Mokkala K, "Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women", Metabolism, 69, pp.43~50 (2017)
- Fasano A, "Zonulin, regulation of tight junctions, and autoimmune diseases", Ann N Y Acad Sci, 1258, pp.25~33 (2012)
- Santisteban MM, "Hypertension-linked pathophysiological alterations in the gut", Circ Res, 120, pp.312~323 (2017)
- Khosravi S, "Study of the prevalence of hypertension and complications of hypertensive disorders in pregnancy", Open J Preven Med, 4, pp.860~867 (2014)
- Helewa ME, "Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy", CMAJ, 157, pp.715~725 (1997)
- Redman CWG, "Preeclampsia: a multi-stress disorder", La Revue de medicine interne, 32S, pp.41~44 (2011)
- Redman CW, "IFPA Senior Award Lecture: making sense of pre-eclampsia–two placental causes of preeclampsia?", Placenta, 35, pp.S20~S25 (2014)
- Smecuol E, "Permeability, zonulin production, and enteropathy in dermatitis herpetiformis", Clin Gastroenterol Hepatol, 3, pp.335~341 (2005)
- Ling X, "Protective effects of bifido bacterium on intestinal barrier function in LPS-induced enterocyte barrier injury of Caco-2 monolayers and in a rat NEC model", PLoS One, 11, pp.e0161635~ (2016)
- Moreno-Navarrete JM, "Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance", PloS One, 7, pp.e37160~ (2012)
- Kirkendall WM, "Recommendations for human blood pressure determination by sphygmomanometers", Circulation, 36, pp.980~988 (1967)
- Yeboah FA, "Adiposity and hyperleptinemia during the first trimester among pregnant women with preeclampsia", Int J Womens Health, 9, pp.449~454 (2017)
- American College of Obstetricians and Gynecologists, "Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy", Obstet Gynecol, 122, pp.1122~1131 (2013)
- Kim S, "Plasma Zonulin, Along With a Unique Gut Microbiome Profile, Are Potential Predictors of Systolic Blood Pressure in Humans", Hypertension, 70(suppl_1), pp.A004~ (2017)
- Lv LJ, "Early-onset preeclampsia is associated with gut microbial alterations in antepartum and postpartum women", Front Cell Infect Microbiol, 9, pp.224~ (2019)
- Zak-Gołąb A, "Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects", Int J Endocrinol, 2013, pp.674106~ (2013)
- Malyszko J, "Transplantation proceedings", pp.2644~2646 (2014), Elsevier
- Ohlsson B, "Higher levels of serum zonulin may rather be associated with increased risk of obesity and hyperlipidemia, than with gastrointestinal symptoms or disease manifestations", Int J Mol Sci, 18(3), pp.582~ (2017)
- Makharia GK, "Intestinal permeabililty in portal hypertension : Still a dilemma", Trop Gastro Enterol, 34, pp.119~122 (2014)
- Yang T, "Gut dysbiosis is linked to hypertension", Hypertension, 65(6), pp.1331~1340 (2015)
- Özogul F, "Effects of specific lactic acid bacteria species on biogenic amine production by foodborne pathogen", Int J Food Sci Tech, 46, pp.478~484 (2011)
- Rossi F, "Quantitative analysis of histidine decarboxylase gene(hdcA)transcription and histamine production by Streptococcus thermophilus PRI60 under conditions relevant to cheese making", Appl Environ Microbiol, 77, pp.2817~2822 (2011)
- Lyte M, "Probiotics function mechanistically as delivery vehicles for neuroactive compounds : microbial endocrinology in the design and use of probiotics", Bioessays, 33, pp.574~581 (2011)
- Lima VJ, "Serum lipid levels in pregnancies complicated by preeclampsia", Sao Paulo Med J, 129, pp.73~76 (2011)
- Belo L, "Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies", Atherosclerosis, 162, pp.425~432 (2002)